Not Tagged
Not Tagged
['leusm']
#asco22 #leusm uy: options in primary refractory and relapsed include immediate allo (but poor outcomes with current approaches; awaiting iomab-b data), limited benefit to multiple serial cytotoxic chemo regimens, so targeted inhibitors will be backbone of therapy for these pts 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)